Thus promoter methylation of candidate TSGs including RASSF1A, FLIP, TSP1, DCR1, DCR2, DR4, DR5, CASP8, and HIC1 was reported at a frequency of >20% of tumours analysed [30–32]. The gene discussed is RASSF1; the disease is neoplasm.